MedPath

Bindarit

Generic Name
Bindarit
Drug Type
Small Molecule
Chemical Formula
C19H20N2O3
CAS Number
130641-38-2
Unique Ingredient Identifier
JQ11LH711M

Overview

Bindarit has been used in trials studying the prevention and treatment of Coronary Restenosis and Diabetic Nephropathy.

Background

Bindarit has been used in trials studying the prevention and treatment of Coronary Restenosis and Diabetic Nephropathy.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2
Completed
Posted: 2011/01/04
Sponsor:
Aziende Chimiche Riu...
Phase 2
Completed
Posted: 2010/04/23
Sponsor:
Aziende Chimiche Riu...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath